Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. | ALHC Alignment Healthcare, Inc. | 13G/A | 0.1% | Mar 31, 2026 | 6mo |
| North Reef Capital Management LP | ALKT Alkami Technology, Inc. | 13G | 7.15% | Mar 31, 2026 | 6mo |
| EARNEST PARTNERS LLC | DAKT Daktronics Inc | 13G | 6.6% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | VC Visteon Corp | 13G | 5.1% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | PNFP Pinnacle Financial Partners, Inc. | 13G/A | 2.64% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | ANRO Alto Neuroscience, Inc. | 13G/A | 3.7% | Mar 31, 2026 | 6mo |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | MXE Mexico Equity & Income Fund Inc | 13G/A | 27.9% | Mar 31, 2026 | 6mo |
| LMR Partners LLP | BTMCQ Bitcoin Depot Inc. | 13G/A | 5.9% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | HLF Herbalife Ltd. | 13G/A | 6.72% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | OKYO OKYO Pharma Ltd | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Redmile Group, LLC | AGMB AgomAb Therapeutics NV | 13G | 5.6% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | PPL PPL Corp | 13G/A | 2.8% | Mar 31, 2026 | 6mo |
| Bin (Tony) Zhao | API Agora, Inc. | 13G/A | 27% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | GLED GalaxyEdge Acquisition Corp | 13G | 5.7% | Mar 31, 2026 | 6mo |
| Deep Track Capital, LP | BCAX Bicara Therapeutics Inc. | 13G/A | 6.21% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | LEU Centrus Energy Corp | 13G/A | 6.4% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | ISTR Investar Holding Corp | 13G/A | 7% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | RYN Rayonier Inc | 13G/A | 7.34% | Mar 31, 2026 | 6mo |
| Global X Management CO LLC | HESM Hess Midstream LP | 13G | 5.5% | Mar 31, 2026 | 6mo |
| LAZARD ASSET MANAGEMENT LLC | BRSL Brightstar Lottery PLC | 13G | 4.9% | Mar 31, 2026 | 6mo |
| CVI Investments, Inc. | CNSY Cerenome, Inc. | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| EAGLE CAPITAL MANAGEMENT LLC | WWD Woodward, Inc. | 13G/A | 4.13% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | CTMX CytomX Therapeutics, Inc. | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| First Light Asset Management, LLC | NPCE NeuroPace Inc | 13G | 8.67% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | TVAI Thayer Ventures Acquisition Corp II | 13G/A | 5.42% | Mar 31, 2026 | 6mo |
| ADAR1 Capital Management, LLC | OKUR OnKure Therapeutics, Inc. | 13G/A | 6% | Mar 31, 2026 | 6mo |
| Paradigm Biocapital Advisors LP | ERAS Erasca, Inc. | 13G/A | 3.3% | Mar 31, 2026 | 6mo |
| Fort Baker Capital Management LP | RAAQ Real Asset Acquisition Corp. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | SAIA Saia Inc | 13G/A | 8.7% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | XAIR Beyond Air, Inc. | 13G/A | 7.25% | Mar 31, 2026 | 6mo |
| Jeffrey T. Green | TTD Trade Desk, Inc. | 13G/A | 11.3% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | KRRO Korro Bio, Inc. | 13G | 7.21% | Mar 31, 2026 | 6mo |
| Lytton, Laurence W. | CREX Creative Realities, Inc. | 13G/A | 8.7% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | WIX Wix.com Ltd. | 13G/A | 12.3% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | PTCT Ptc Therapeutics, Inc. | 13G/A | 8.7% | Mar 31, 2026 | 6mo |
| BIOTECHNOLOGY VALUE FUND L P | GLUE Monte Rosa Therapeutics, Inc. | 13G/A | 6.3% | Mar 31, 2026 | 6mo |
| Lynrock Lake LP | MRAM Everspin Technologies Inc. | 13G/A | 4.2% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | DUOT Duos Technologies Group, Inc. | 13G | 6.45% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | BRKR Bruker Corp | 13G/A | 11.1% | Mar 31, 2026 | 6mo |
| GREAT POINT PARTNERS LLC | PMN ProMIS Neurosciences Inc. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | FLEX Flex Ltd. | 13G | 5.5% | Mar 31, 2026 | 6mo |
| Jain Global LLC | DMRA Damora Therapeutics, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | MDGL Madrigal Pharmaceuticals, Inc. | 13G/A | 8.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | NPB Northpointe Bancshares Inc | 13G/A | 13.1% | Mar 31, 2026 | 6mo |
| Valiant Capital Management, L.P. | CORZ Core Scientific, Inc. | 13G/A | 5.1% | Mar 31, 2026 | 6mo |
| Fourthstone LLC | ATLO Ames National Corp | 13G | 7.71% | Mar 31, 2026 | 6mo |
| Verition Fund Management LLC | FDGX First Digital Acquisition Corp Ltd. | 13G/A | 2.9% | Mar 31, 2026 | 6mo |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | WDAY Workday, Inc. | 13G | 5.07% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | ADGM Adagio Medical Holdings, Inc. | 13G/A | 55.4% | Mar 31, 2026 | 6mo |
| Boston Partners | FTDR Frontdoor, Inc. | 13G/A | 6.75% | Mar 31, 2026 | 6mo |